Hip Disease
37
6
6
18
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.4%
2 terminated out of 37 trials
90.0%
+3.5% vs benchmark
19%
7 trials in Phase 3/4
6%
1 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (37)
Cardiac Index and General Anesthesia Without Opioid.
MDR - PMCF Study for RingLoc Bipolar Acetabular Cup and Endo II Femoral Heads
The Effect of Dexamethasone Administration Route in PENG Block for Pediatric Hip Surgery
Pericapsular Nerve Group Block Versus Intrathecal Morphine for Analgesia After Total Hip Arthroplasty
Treatment of Osteoarthritis of the Hip Joint With Intra-articular Injection of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells.
Observational Study Conducted on Patients Receiving the ESOP 2 Stem to Confirm Security and Performance of the Device
Pediatric Orthopaedic Implant Safety & Efficacy
ACE Acetabular Cup UK Multi-centre PMCF Study
ACE Acetabular Cup Spanish PMCF Study
Effectiveness and Safety of the Electrically Powered Orthopedic Exercise Device on Gait Ability in Patients With Hip Joint Diseases
PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery
MDR - PMCF Study for Taperloc Complete Stems
Multicenter Study for Robotic Arm-assisted THA 4.0 System: Hip Spine Relationship
MDR - M/L Taper With Kinectiv Technology Stems and Necks
CLIC1 in Patients Presenting PD
Trochanteric Bursal Repair After a Total Hip Replacement - Are There Benefits During the First 90 Days
PENG Block vs. ESP Block for Pediatric Hip Surgery
MDR - G7 Neutral and G7 Freedom Constrained Neutral Acetabular Liners
Everglade Stem, World Cup and World Liner Post Market Clinical Follow-up
MRI-based 3D Hip Labrum and Cartilage Morphology in Patients With Hip Deformities Compared to Asymptomatic Volunteers